Page last updated: 2024-08-21

pyrazines and Adenocarcinoma, Alveolar

pyrazines has been researched along with Adenocarcinoma, Alveolar in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albain, KS; Chansky, K; Crowley, J; Davies, AM; Gandara, DR; Gumerlock, PH; Lara, PN; Vogel, SJ	1
Belani, CP; Davies, AM; Edelman, MJ; Gandara, DR; Gitlitz, B; Lara, PN; Longmate, J; Ramalingam, SS; Reckamp, K; Salgia, R; Villalona-Calero, M; Vokes, EE; Wright, JJ	1
Edelman, MJ	1
Govindan, R; Narra, V; Pillot, G; Subramanian, J	1
Cadranel, JL; Garfield, DH	1

Trials

2 trial(s) available for pyrazines and Adenocarcinoma, Alveolar

Article	Year
Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:1 Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Prognosis; Pyrazines; Survival Rate; Treatment Outcome	2009
Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:10 Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; California; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Pyrazines; Survival Rate; Treatment Outcome	2011

Article

Year

Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339).

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:1

Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Prognosis; Pyrazines; Survival Rate; Treatment Outcome

2009

Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003).

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:10

Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; California; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Pyrazines; Survival Rate; Treatment Outcome

2011

Other Studies

3 other study(ies) available for pyrazines and Adenocarcinoma, Alveolar

Article	Year
Lung cancer - Second Annual Winter Conference. IDrugs : the investigational drugs journal, 2005, Volume: 8, Issue:5 Topics: Adenocarcinoma, Bronchiolo-Alveolar; Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Chemotherapy, Adjuvant; ErbB Receptors; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Molecular Structure; Paclitaxel; Pyrazines; Quinazolines	2005
Response to bortezomib (velcade) in a case of advanced bronchiolo-alveolar carcinoma (BAC). A case report. Lung cancer (Amsterdam, Netherlands), 2006, Volume: 51, Issue:2 Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Humans; Lung Neoplasms; Male; Pyrazines; Tomography, X-Ray Computed	2006
Possible mechanism(s) of action of bortezomib in a patient with bronchioloalveolar carcinoma. Lung cancer (Amsterdam, Netherlands), 2007, Volume: 57, Issue:2 Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Humans; Lung Neoplasms; Male; Models, Biological; Proteasome Inhibitors; Pyrazines; Tumor Suppressor Protein p53	2007